Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26 USD | -11.56% | -14.36% | +137.57% |
May. 21 | Leerink Partners Starts Q32 Bio With Outperform Rating | MT |
May. 09 | Q32 Bio Inc. Provides Corporate Update | CI |
Evolution of the average Target Price on Q32 Bio Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Q32 Bio Inc.
Leerink Partners | |
Oppenheimer | |
Piper Sandler | |
Baird | |
Chardan Research | |
RBC Capital Markets | |
BTIG | |
Credit Suisse | |
Canaccord Genuity | |
HC Wainwright | |
BofA Securities | |
Chardan | |
Stifel Nicolaus |
EPS Revisions
- Stock Market
- Equities
- QTTB Stock
- Consensus Q32 Bio Inc.